Picture of Biosenic SA logo

BIOS Biosenic SA Share Price

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-36.04%
3m-39.44%
6m-30.4%
1yr-81.14%
Volume Change (%)
10d/3m+16.76%
Price vs... (%)
52w High-83.77%
50d MA-30.97%
200d MA-48.7%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Biosenic SA EPS forecast chart

Profile Summary

Bone Therapeutics SA is a Belgium-based company developing cell therapy products. The Company develops cell therapy products for the treatment and regeneration of bone tissue and bone reconstruction applications, osteonecrosis, ununited fractures, and maxillo-facial reconstruction. It is engaged in research, enable adult stem cell isolation, expansion, and osteogenic differentiation.The Company’s therapeutic area focus is bone diseases, with extensions to joint, mainly osteoarthritis and disc degeneration.

Directors

Last Annual
December 31st, 2022
Last Interim
June 30th, 2023
Incorporated
June 22nd, 2006
Public Since
February 6th, 2015
No. of Employees
12
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
be flag iconEuronext - Brussels
Shares in Issue
178,154,371
Blurred out image of a map
Address
Rue Granbonpre 11, Batiment H (bte 24), MONT-SAINT-GUIBERT, 1435
Web
http://www.bonetherapeutics.com
Phone
+32 493097366
Contact
Alexia Rieger
Auditors
BDO Bedrijfsrevisoren – Réviseurs d’entreprises SRL

BIOS Share Price Performance

Upcoming Events for BIOS

Q4 2023 Bone Therapeutics SA Earnings Release

Q1 2024 Bone Therapeutics SA Earnings Release

Bone Therapeutics SA Annual Shareholders Meeting

Similar to BIOS

Picture of Fagron NV logo

Fagron NV

be flag iconEuronext - Brussels

Picture of Hyloris Pharmaceuticals SA logo

Hyloris Pharmaceuticals SA

be flag iconEuronext - Brussels

Picture of Mithra Pharmaceuticals SA logo

Mithra Pharmaceuticals SA

be flag iconEuronext - Brussels

Picture of Financiere de Tubize SA logo

Financiere de Tubize SA

be flag iconEuronext - Brussels

Picture of UCB SA logo

UCB SA

be flag iconEuronext - Brussels

FAQ